CIM: Who are your customers?
GCCM: Under the medical marijuana treatment regulations our customers are the patients who meet the qualifications under Amendment 2 for a medical marijuana card.
CIM: Will Gulf Coast Canna Meds be branded or will it be white labeled?
GCCM: Branded.
CIM: Will Gulf Coast Canna Meds be branded or will it be white labeled?
GCCM: Florida is vertically integrated and thus we derive revenue via sales to patients.
CIM: What % of your revenues will come from cultivation, % from extraction and % from dispensing?
GCCM: 100% from dispensing.
CIM: Seems like you’re in several different businesses, will that distract you from your core business?
GCCM: Florida requires vertical integration and there are no other options currently in the Florida market.
CIM: Will you be conducting strain R&D?
GCCM: Yes.
CIM: How will you maintain consistency in levels of THC and CBD?
GCCM: Through our license formulations and internal testing as well as independent testing to conform with our SOP.
105